[ad_1]
San Diego, December 30, 2021 (Global News Agency)-Johnson Fistel, LLP, a shareholder’s equity law firm, announced its representation of Instadose Pharma Corp (“Instadose” or “Company”) (OTC:National Bureau of Statistics). The class action represents shareholders who purchased Instadose securities from December 8, 2020 to November 24, 2021 (inclusive) (the “class action period”).To be the lead plaintiff in this class action, you must be no later than February 28, 2022.
What action can I take at this time? If you have suffered significant losses and are interested in learning more about becoming the lead plaintiff, please contact Jim Baker (jimb@johnsonfistel.com) By email or phone 619-814-4471. If sending by email, please include the phone number. In addition, you can:
[[[[ The full story on Benzinga.com [ad_2]
Source link
